UPDATE : Tuesday, October 23, 2018
상단여백
Samsung BioLogics denies accounting irregularities
Shim Byung-hwa (left), Samsung BioLogics’ business innovation team leader, ...
by Lee Han-soo  |  2018-05-02 17:12
라인
VC investment in biomedicine rises 200% y-o-y in Q1
New venture capital investment in the biomedical industry rose more than 20...
by Nam Doo-hyun  |  2018-04-30 14:14
라인
Chong Kun Dang wins US patent for anemia biosimilar
Chong Kun Dang said Friday that it has acquired a patent regarding the form...
by Lee Han-soo  |  2018-04-27 15:39
라인
Hugel posts ￦45.8 billion in Q1 sales
Hugel said Tuesday that it recorded 45.8 billion won ($42.3 million) in the...
by Lee Han-soo  |  2018-04-26 12:51
라인
Samsung BioLogics posts ￦131 billion in Q1 sales
Samsung BioLogics said Tuesday that it recorded 131 billion won ($121.1 mil...
by Lee Han-soo  |  2018-04-25 17:47
라인
Pharma shares on the rise since early this year
Pharmaceutical and biotech shares have recently suffered declines, but most...
by Nam Doo-hyun  |  2018-04-25 13:56
라인
NIBEC wins anti-cancer peptide patent in the US
Nano Intelligence Biomedical Engineering Corporation (NIBEC) said Monday th...
by Lee Han-soo  |  2018-04-23 15:15
라인
Kolon unveils trial results for Invossa at cartilage repair conference
Kolon Life Science said Friday that it has presented its local phase 3 clin...
by Lee Han-soo  |  2018-04-20 15:57
라인
Blockbuster Remicade losing out to Korean biosimilars in US
Biosimilar drugs developed by Korean pharmaceutical firms are gradually car...
by So Jae-hyeon  |  2018-04-19 15:39
라인
Hanmi gets FDA nod for nonalcoholic steatohepatitis treatment trials
Hanmi Pharmaceutical said Thursday that it has received approval to go ahea...
by Lee Han-soo  |  2018-04-19 15:29
라인
Biotech stocks could be overpriced: analysts
Analysts are warning investors that biotech shares could be overpriced, as ...
by Nam Doo-hyun  |  2018-04-19 13:34
라인
Pharmbio to market Shionogi’s dyspareunia treatment
Shionogi Inc. President and CEO John Keller (left) and Pharmbio Korea CEO N...
by Lee Han-soo  |  2018-04-18 14:10
라인
ViroMed confirms VM202’s pain control in animal test
ViroMed said it has confirmed that VM202, an investigational gene therapy b...
by Nam Doo-hyun  |  2018-04-18 11:39
라인
‘Genexine’s pipelines worth more than ￦3 trillion’
Biotech firm Genexine’s major pipelines could be worth more than 3 trillion...
by Nam Doo-hyun  |  2018-04-16 15:48
라인
Daewoong opens biotech research lab in Indonesia
Daewoong Pharmaceutical said it has established a biotech research center a...
by So Jae-hyeon  |  2018-04-12 11:37
라인
Biotech CEOs roll up sleeves for global biz
CEOs of Korea’s major biotech companies are directly involving in marketing...
by So Jae-hyeon  |  2018-04-10 12:09
라인
Samsung Bioepis settles patent disputes with AbbVie on Humira
Samsung Bioepis said Thursday that it has settled a patent dispute with Abb...
by Lee Han-soo  |  2018-04-06 15:21
라인
CTC Bio gets sales nod for erectile dysfunction treatment in Vietnam
CTC Bio said Tuesday that it has acquired marketing approval for its erecti...
by Lee Han-soo  |  2018-04-04 10:59
라인
Steelmaker POSCO to challenge biotech sector
Korea’s largest steelmaker POSCO is entering the pharmaceutical market.Kwon...
by So Jae-hyeon  |  2018-04-03 11:58
라인
Toolgen to develop hepatitis B treatment
Toolgen said Friday that it would develop a chronic hepatitis B treatment u...
by Lee Han-soo  |  2018-03-30 17:28
-12345678910-
Anticoagulant Lixiana outpaces Eliquis in Q3 prescriptionsAnticoagulant Lixiana outpaces Eliquis in Q3 prescriptions
여백
Most viewed
여백
Opinion
[Column]‘Doctors made patients want to bring CCTVs in operating rooms’
[Column]‘Doctors made patients want to bring CCTVs in operating rooms’
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] Pyongyang summit prelude for inter-Korean health community
[Column] What makes telemedicine controversial?
[Column] What makes telemedicine controversial?
여백
Back to Top